Received Feb 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | x449y | IM |
numbness; tingling radiating from their shoulder to their fingers; This non-serious case was reported by a other health professional and described the occurrence of numbness of upper extremities in a 35-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number x449y, expiry date 20-OCT-2026) for prophylaxis. On 26-SEP-2024, the patient received Boostrix (intramuscular) .5 ml. On 26-SEP-2024, less than a day after receiving Boostrix, the patient experienced numbness of upper extremities (Verbatim: numbness) and tingling of extremity (Verbatim: tingling radiating from their shoulder to their fingers). The outcome of the numbness of upper extremities and tingling of extremity were not resolved. It was unknown if the reporter considered the numbness of upper extremities and tingling of extremity to be related to Boostrix. It was unknown if the company considered the numbness of upper extremities and tingling of extremity to be related to Boostrix. Additional Information: GSK Receipt Date : 21-FEB-2025 Patient received boostrix vaccine, complained of numbness and tingling radiating from their shoulder to their fingers on the arm the vaccine was administered on. Still felt it months after receiving the vaccine. Started day after they received the vaccine (Numbness). Symptoms were not treated.